China opens public consultation on export control revisions covering AI, biomedicine, solar technologies
Editorial responsibility
- No named human review is recorded for this page.
- Source reporting is collected, normalized, translated or condensed automatically when needed.
- Automatically published source-backed update
China's Ministry of Commerce and Ministry of Science and Technology on October 16 opened public consultation on revisions to the Catalogue of Technologies Prohibited or Restricted from Export, covering 40 technologies across artificial intelligence, biomedicine, and solar photovoltaics, and imposed temporary registration management on related technology exports. The AI section covers 23 technologies related to large models, intelligent agents, computing clusters, and information processing; technologies already in the public domain through open-source release or academic publication would not be included. The biomedicine section covers five technologies related to cell and gene therapy, small nucleic acid drugs, and pathogenic microorganisms; outbound licensing models that do not involve transfer of ownership would receive facilitative measures such as automatic licensing. The photovoltaic section covers 12 technologies related to polysilicon manufacturing, wafer manufacturing, and cell manufacturing, with management also extending to key and core equipment carrying the relevant technologies.
Source report
October 16 — China's Ministry of Commerce and Ministry of Science and Technology have jointly opened a public consultation on revisions to the Catalogue of Technologies Prohibited and Restricted from Export, alongside the implementation of temporary registration management for related technology exports.
The proposed revisions cover 40 technologies across three fields: artificial intelligence, biomedicine, and photovoltaics.
Artificial Intelligence (23 technologies)
- Includes technologies related to large models, intelligent agents, computing clusters, and information processing.
- Technologies that have already entered the public domain through open-source release, published academic papers, or similar means will not be subject to management.
Biomedicine (5 technologies)
- Includes technologies related to cell and gene therapy, small nucleic acid drugs, and pathogenic microorganisms.
- Outbound licensing models that do not involve transfer of ownership will be eligible for facilitation measures such as automatic licensing.
Photovoltaics (12 technologies)
- Includes technologies related to polysilicon manufacturing, wafer manufacturing, and cell manufacturing.
- The scope of technology management also covers key and core equipment that embodies the relevant technologies.
Source
domesticEastern
Part of this Story
China Proposes Export Controls on 40 AI, Biomedicine and Solar Technologies